Objective: In this research the role of adenosine A1 receptors of the entorhinal cortex on piriform cortex- kindled seizures was investigated.
Materials and Methods: Animals were kindled by daily electrical stimulation of the piriform cortex. Then N6-Cyclohexyladenosine (CRA), an adenosine A1receptor agonist, at concentrations of 1,10 and 100 µM and 1,3-dimethyl-8 cyclopenthylxanthine (CPT), an adenosine A1 receptor antagonist, at concentrations of 50 and 100 µM were injected into the entorhinal cortex. Animals were stimulated 5 min after drug injection and seizure parameters were recorded. Also in another group of animals, CPT (50 µM) was injected 5 min before CRA (100 µM).
Results: CRA at a concentration of 100 µM decreased the after discharge duration (ADD), stage 5 duration (S5D), and seizure duration (SD), and increased the latency to stage 4 of the seizure (S4L) significantly. CRA at a concentration of 10 µM decreased only SD and increased S4L significantly. On the other hand bilateral microinjection of CPT into the entorhinal cortex at a concentration of 100 µM increased ADD, S5D, and SD, and reduced S4L significantly. Pretreatment of animals with CPT (50 µM), 5 min before CRA (100 µM), reduced the effect of CRA on seizure parameters.
Conclusion: These results suggest that adenosine A1 receptors activity in the entorhinal cortex reduces piriform cortex kindled seizures.